Latest Capital Raises News

Paradigm Biopharmaceuticals has upsized a $14 million placement and launched a $2 million SPP, boosting its cash runway to around $45 million. This capital injection supports the ongoing Phase 3 trial for knee osteoarthritis, with interim results expected in Q3 2026.

PYC Therapeutics has gained Orphan Drug Designation from the European Medicines Agency for its VP-001 candidate targeting Retinitis Pigmentosa type 11, enhancing its regulatory and commercial pathway in Europe.

Babylon Pump & Power’s shares remain suspended from ASX trading as the company delays disclosure of a material transaction and capital raising, prolonging market uncertainty beyond the initial deadline.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

SenSen Networks reported a 17% increase in annual recurring revenue to $11 million and positive operating cash flow of $0.9 million in Q3 FY26 despite supply chain disruptions delaying some projects. The company’s full-year EBITDA is expected to improve significantly over FY25.

Corella Resources has agreed to acquire a majority interest in the Chobe Project, a highly prospective niobium and rare earths ground in Western Australia’s West Arunta, supported by a heavily oversubscribed $5 million capital raise.

Corella Resources has agreed to acquire a majority interest in the Chobe Project, expanding its footprint in Western Australia’s emerging rare earths and niobium hotspot. The acquisition is backed by a heavily oversubscribed $5 million capital raise.

Beetaloo Energy has launched a $5 million Share Purchase Plan at $0.28 per share, following a $66.3 million institutional placement at the same price. The SPP aims to fund ongoing development activities ahead of first gas production in late 2026.

Altair Minerals has landed a A$28.2 million strategic placement from Endeavour Mining’s subsidiary at a premium, boosting its treasury to about A$40 million and enabling a major expansion of exploration at the Greater Oko gold project in Guyana.

Solstice Minerals has pushed the boundaries of its Nanadie Copper-Gold Project in WA, completing the deepest drillhole to date and logging visible copper sulphides well below previous resource levels. Assay results are pending, but early signs point to meaningful extensions of the mineralised system.

88 Energy has amended its Participation Agreement with Burgundy Xploration, extending funding milestones to align with Burgundy’s US IPO process while securing US$400,000 in near-term payments and enhanced lease security. The Franklin Bluffs-1H well spud is now expected in Q1 2027, slightly delayed but underpinned by strong capital commitment.

X2M Connect accelerated revenue growth in Q3 FY26 with a 67% increase, driven by strong demand in South Korea and new Australian smart community deals. The company’s capital raise and expanding customer base underpin its push into new markets despite ongoing cash burn.